Affiliation:
1. Laboratory of Cellular and Molecular Biology, National Cancer Institute, 1 and
2. Oral and Pharyngeal Cancer Branch, National Institute of Dental Research, 2 Bethesda, Maryland 20892;
3. Department of Microbiology, Mount Sinai School of Medicine, New York, New York 10029 3 ; and
4. The Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 191074
Abstract
ABSTRACT
In the present study, we investigated the potential role of insulin-like growth factor I (IGF-I) receptor (IGF-IR) in cell proliferation by overexpressing it in 32D myeloid progenitor cells. The overexpression of IGF-IR caused the transfectants to proliferate in response to IGF-I in the absence of insulin receptor substrate (IRS) expression. The activation of overexpressed wild-type IGF-IR, but not that of an ATP-binding mutant of IGF-IR, resulted in the increased tyrosine phosphorylation of several intracellular proteins, including SHC, Src homology 2-containing inositol-5-phosphatase, protein kinase C-δ, and Erk2. Grb2 association with SHC and mitogen-activated protein kinase (MAPK) activity was also enhanced in response to IGF-I stimulation. Interestingly, the stimulation of the IGF-IR transfectants with interleukin 4 (IL-4) also resulted in strong mitogenesis independent of IRS expression. Moreover, IGF-I and/or IL-4 induced long-term cell growth of the IGF-IR transfectants. IL-4 was able to synergize with IGF-I for DNA synthesis, even in the parental 32D cells and a pro-B-cell line, Baf3, indicating the physiological importance of the two growth factors in hematopoietic cell proliferation. IL-4 stimulation of the IGF-IR transfectants resulted in enhanced tyrosine phosphorylation of SHC, Erk2, and signal transducer and activator of transcription 6 (STAT6) proteins. Both IL-4 and IGF-I were able to induce c-
myc
early response gene expression, and this expression was maximal in the presence of both factors. Finally, we demonstrated that a MAPK kinase inhibitor was able to suppress mitogenesis of the IGF-IR transfectants in response to IGF-I and/or IL-4. Together, our results suggest that IL-4 synergizes with IGF-I for hematopoietic cell proliferation, likely through cross talk between SHC/Grb2/MAPK and STAT6 pathways and through c-
myc
gene up-regulation.
Publisher
American Society for Microbiology
Subject
Cell Biology,Molecular Biology
Reference52 articles.
1. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max.
2. The insulin-like growth factor I receptor: a key to tumor growth;Baserga R.;Cancer Res.,1995
3. The IGF-I receptor in cell growth, transformation and apoptosis;Baserga R.;Biochim. Biophys. Acta,1997
4. Signaling via the insulin-like growth factor-I receptor: does it differ from insulin receptor signaling?;Blakesley V. A.;Cytokine Growth Factor Rev.,1996
5. SHIP modulates immune receptor responses by regulating membrane association of Btk;Bolland S.;Immunity,1998
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献